Our support. Your success.
The Board of Directors provides professional guidance for all business-oriented aspects of the Vision Ophthalmology Group. Based on their extensive experience in ophthalmology, the board provides analysis and insights that contribute to the groups strategy development.
Joined in 2015
Chair of the Board of Directors and actively works with the CEO in developing the company
Andrew has over 35 years experience in the Ophthalmology business area having held several senior positions in sales and marketing within Iolab (Johnson and Johnson) and Pharmacia International in Sweden and Australasia focused on ophthalmic medical devices. Andrew was one of the founder members and for over 27 years the majority shareholder and Managing Director of Spectrum Ophthalmics the UK’s largest independent ophthalmic surgical and diagnostic products distributor. Andrew in more recent years has successfully exited several ophthalmic businesses. Having held a board position in Spectrum – Thea Pharmaceuticals UK, a joint venture that was founded in 2008 (a collaboration with Laboratoires Thea – France) and resulted in the successful acquisition in to a fully integrated subsidiary during 2014. Andrew has helped develop other successful businesses including Medicel AG the leader in intraocular lens delivery systems which was acquired in 2011 by Halma Plc.
Joined in 2015
Member of the advisory board
International executive with more than 25 years of experience from the life science sector, including 12 years at Medtronic in different positions such as SVP & President. Significant experience from both public and private corporate boards, including several as Chairman. Multiple successful M&A transactions.